Codexis Inc (CDXS)

Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
INDUSTRIAL ORGANIC CHEMICALS
CEO:
John J. Nicols
Employees:
260
200 PENOBSCOT DRIVE, REDWOOD CITY, CA 94063
650-421-8100

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company also provides biocatalyst screening and protein engineering services. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.

Data derived from most recent annual or quarterly report
Market Cap 544.636 Million Shares Outstanding65.304 Million Avg 30-day Volume 1.022 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.21
Price to Revenue5.058 Debt to Equity0.2572 EBITDA-10.679 Million
Price to Book Value4.2827 Operating Margin-14.8509 Enterprise Value613.957 Million
Current Ratio4.841 EPS Growth0.216 Quick Ratio6.266
1 Yr BETA 1.8879 52-week High/Low 42.01 / 6.15 Profit Margin-14.0296
Operating Cash Flow Growth34.5262 Altman Z-Score3.9486 Free Cash Flow to Firm -121.739 Million
Earnings Report2022-11-03
View SEC Filings from CDXS instead.

View recent insider trading info

Funds Holding CDXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CDXS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-07-14:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2022-07-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-14:
    Item 8.01: Other Events
  • 8-K: filed on 2021-09-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-25:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    77.5 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    77.5 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    NICOLS JOHN J

    • Director
    2,084,358 2022-08-12 5

    DILLY STEPHEN GEORGE SEE REMARKS

    • Officer
    • Director
    700,000 2022-08-01 2

    WOLF DENNIS P

    • Director
    42,198 2022-06-14 4

    SMITH DAVID V

    • Director
    88,570 2022-06-14 2

    YANG PATRICK Y

    • Director
    53,785 2022-06-14 3

    DORGAN BYRON L

    • Director
    178,859 2022-06-14 3

    MOORE ALISON

    • Director
    33,974 2022-06-14 1

    AAKER JENNIFER

    • Director
    31,609 2022-06-14 1

    MARTINBOROUGH ESTHER

    • Director
    23,331 2022-06-14 1

    TAYLOR DEAN ROSS JR SVP, CHIEF FINANCIAL OFFICER

    • Officer
    39,778 2022-03-05 2

    KELLEY BERNARD J

    • Director
    206,136 2021-08-10 0

    BARUCH THOMAS R

    • Director
    33,093 2020-06-12 0

    GLAUB KATHLEEN SEREDA

    • Director
    68,481 2019-06-11 0

    CHENG PAM P.

    • Director
    69,589 2019-06-11 0

    LALONDE JAMES SVP, R&D

    • Officer
    133,402 2019-05-13 0

    SANGSTER GORDON SVP & CHIEF FINANCIAL OFFICER

    • Officer
    134,453 2019-03-20 0

    ALDRIDGE MICHAEL D. SEE REMARKS

    • Officer
    0 2018-05-17 0

    VIVO VENTURES FUND VII, L.P.

    VIVO VENTURES VII AFFILIATES FUND, L.P.

    VIVO VENTURES VII, LLC

    • 10% Owner
    No longer subject to file 2017-09-14 0

    SHEEHY DOUGLAS T. SEE REMARKS

    • Officer
    247,617 2016-03-05 0

    CMEA VENTURES LIFE SCIENCES 2000 LP

    CMEA VENTURES LIFE SCIENCES 2000, CIVIL LAW PARTNERSHIP

    CMEA VENTURES LS MANAGEMENT 2000, L.P.

    COLLIER DAVID J

    HANDELSMAN KARL D.

    • Director
    • 10% Owner
    0 2014-11-10 0

    KARSNER ALEXANDER

    • Director
    78,519 2014-01-02 0

    TOBIN MATTHEW SVP, RESEARCH & DEVELOPMENT

    • Officer
    78,707 2013-05-16 0

    O'TOOLE DAVID D SVP & CHIEF FINANCIAL OFFICER

    • Officer
    115,384 2013-03-04 0

    ANTON DAVID L. SVP, BIOINDUSTRIALS

    • Officer
    93,777 2013-02-10 0

    SEUFER-WASSERTHAL PETER SVP, PHARMACEUTICALS

    • Officer
    93,064 2013-01-24 0

    HO MARK PRINCIPAL ACCOUNTING OFFICER

    • Officer
    12,654 2012-07-10 0

    STRUMPH PETER M INTERIM PRESIDENT AND CEO

    • Officer
    60,756 2012-06-01 0

    DOWD BRIAN PAUL INTERIM CFO

    • Officer
    28,310 2012-06-01 0

    SARRET JOSEPH J. SVP AND CBO

    • Officer
    87,333 2012-03-07 0

    SHAW ALAN PRESIDENT AND CEO

    • Officer
    • Director
    277,000 2011-12-15 0

    MIZUTANI PEDRO ISAMU

    • Director
    0 2011-07-15 0

    RAIZEN ENERGIA PARTICIPACOES S.A.

    ISPAGNAC PARTICIPACOES LTDA.

    ROYAL DUTCH SHELL PLC

    COSAN S.A. INDUSTRIA E COMERCIO

    COSAN LTD.

    • 10% Owner
    5,573,319 2011-06-01 0

    ISPAGNAC PARTICIPACOES LTDA.

    ROYAL DUTCH SHELL PLC

    • 10% Owner
    No longer subject to file 2011-06-01 0

    ISPAGNAC PARTICIPACOES LTDA.

    • 10% Owner
    5,573,319 2011-05-31 0

    SHELL BRAZIL HOLDING B.V.

    • 10% Owner
    No longer subject to file 2011-05-31 0

    EQUILON ENTERPRISES LLC

    • 10% Owner
    5,573,319 2011-05-20 0

    LAWSON ROBERT J SVP AND CFO

    • Officer
    44,000 2011-05-11 0

    MAXYGEN INC

    • 10% Owner
    No longer subject to file 2010-12-14 0

    PASTERNACK BRUCE A

    • Director
    10,000 2010-08-12 0

    SULAT JAMES R

    • Director
    • 10% Owner
    No longer subject to file 2010-04-27 0

    EQUILON ENTERPRISES LLC

    ROYAL DUTCH SHELL PLC

    • 10% Owner
    5,573,319 2010-04-27 0

    BIOMEDICAL SCIENCES INVESTMENT FUND PTE LTD.

    EDB INVESTMENTS PTE LTD.

    • 10% Owner
    No longer subject to file 2010-04-27 0

    WONG MUN YEW

    • Director
    No longer subject to file 2010-04-27 0

    CMEA VENTURES LIFE SCIENCES 2000 LP

    CMEA VENTURES LIFE SCIENCES 2000, CIVIL LAW PARTNERSHIP

    CMEA VENTURES LS MANAGEMENT 2000, L.P.

    BARUCH THOMAS R

    COLLIER DAVID J

    HANDELSMAN KARL D.

    • Director
    • 10% Owner
    0 2010-04-21 0

    MAXYGEN INC

    SULAT JAMES R

    • Director
    • 10% Owner
    666,666 2010-04-21 0

    STRENG CHRIS

    • Director
    0 2010-04-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-15 M 39,000 $2.32 a 1,061,679 direct yes -0.3584 0.0 1 -0.3584 2

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-15 S 39,000 $8.78 d 1,022,679 direct yes -0.3584 0.0 1 -0.3584 2

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-15 M 39,000 d 0 direct yes

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-12 M 38,500 $2.32 a 1,061,179 direct yes -0.3584 0.0 1 -0.3584 2

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-12 S 38,500 $8.62 d 1,022,679 direct yes -0.3584 0.0 1 -0.3584 2

    NICOLS JOHN J - Director

    2022-08-16 16:03:31 -0400 2022-08-12 M 38,500 d 39,000 direct yes

    DILLY STEPHEN GEORGE - Director - Officer SEE REMARKS

    2022-08-03 18:25:54 -0400 2022-08-01 A 700,000 a 700,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CODEXIS INC CDXS 2022-08-19 22:15:05 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 21:45:05 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 21:15:03 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 20:45:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 20:15:05 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 19:45:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 19:15:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 18:45:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 18:15:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 17:45:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 17:15:04 UTC 1.6547 0.6653 1700000
    CODEXIS INC CDXS 2022-08-19 16:45:04 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 16:15:04 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 15:45:04 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 15:15:05 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 14:45:04 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 14:15:04 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 13:45:03 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 13:15:05 UTC 1.6456 0.6744 1700000
    CODEXIS INC CDXS 2022-08-19 12:45:04 UTC 1.6456 0.6744 1700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund CDXS -72.0 shares, $-803.52 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund CDXS -134.0 shares, $-1495.44 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund CDXS -60.0 shares, $-669.6 2020-03-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund CDXS -2100.0 shares, $-47586.0 2021-06-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio CDXS -46900.0 shares, $-1090894.0 2021-09-30 N-PORT

    Elevate your investments